PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

GEN reports on biotech acquisition deals in 2010 that topped $1 billion

2011-01-11
(Press-News.org) New Rochelle, NY, January 10, 2011—The mega-mergers of 2009 did not continue into 2010. While the three biggest acquisitions in 2009 each had a price tag of more than $40 billion, only last year's top purchase got above that mark, according to an evaluation of reported deals conducted by Genetic Engineering & Biotechnology News (GEN) (http://www.genengnews.com/). The only other mega takeover for the year, sanofi-aventis' move to buy Genzyme, is still being worked out.

A look at 2010's buyouts that crossed the $1billion mark (http://www.genengnews.com/gen-news-highlights/acquisition-deals-in-2010-that-topped-1b/81244443/) reveals interesting similarities with major acquisitions from past years. Prior finalists make a repeat appearance, and most organizations that have reported consolidation say that the mergers have been positive.

"I think the uncertainty surrounding the sanofi-aventis/Genzyme story put a break on the number of large mergers and acquisitions that might actually have taken place," says John Sterling, Editor in Chief of GEN. "Once that deal gets done, other big M&As are likely to follow."

Novartis' $41 billion purchase of Alcon, which has a significant portfolio of eye disease therapies, topped the list of acquisitions last year. Sanofi-aventis' bid for Genzyme of $18.5 billion, which still has to clear, grabbed the number two spot. Merck's foray into life science tools and services with its $5.2 billion acquisition of Millipore was next, followed by Teva paying €3.625 billion for ratiopharm to up its generic drug dominance.

Fifth place went to Astellas Pharma for picking up OSI Pharmaceuticals for $4 billion. Pfizer, 2009's top bidder, made the number six spot with its takeover of King Pharmaceuticals for $3.6 billion. Other acquisition deals that crossed the billion-dollar mark included Grifols/Talecris, Celgene/Abraxis, Thermo Fisher Scientific/Dionex, and Johnson & Johnson/Crucell.

INFORMATION:

About GEN

Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. Additionally, GEN hosts a networking platform called GENconnect, which comprises Communities such as All Things PCR, Next-Generation Sequencing, Biomarkers, and more. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. For more information visit the GEN website (http://www.genengnews.com/).

Genetic Engineering & Biotechnology News (http://www.genengnews.com/, which is published 21 times a year by Mary Ann Liebert Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.

END



ELSE PRESS RELEASES FROM THIS DATE:

Abstinence, heavy drinking, binge drinking associated with increased risk of cognitive impairment

2011-01-11
Amsterdam, The Netherlands, January 10, 2011 -- Previous research regarding the association between alcohol consumption and dementia or cognitive impairment in later life suggests that mild to moderate alcohol consumption might be protective of dementia. However, most of the research has been conducted on subjects already rather elderly at the start of the follow-up. A new study published in the December issue of the Journal of Alzheimer's Disease addresses this problem with a follow-up of more than two decades. The study, conducted at the University of Turku, University ...

Nuclear receptors reveal possible interventions for cancer, obesity

Nuclear receptors reveal possible interventions for cancer, obesity
2011-01-11
HOUSTON, Jan. 10, 2011 – Research with significant implications in the treatment and intervention of cancer and obesity has been published recently in two prestigious journals by University of Houston (UH) biochemist Dr. Jan-Åke Gustafsson. In an invited review in the Journal of Biological Chemistry, the most-cited biomedical research journal in the world, Gustafsson and his team summarize the most recent results pertaining to the function of a nuclear receptor called estrogen receptor beta, or ERbeta, the biological and medical importance of which Gustafsson and his ...

CT helps identify bullet trajectories

2011-01-11
OAK BROOK, Ill. – Multidetector computed tomography (MDCT) provides an efficient, effective way to analyze wounds from bullets and explosive devices, according to a study published online and in the March issue of Radiology. "The information provided by MDCT has the potential to improve patient care and aid in both military and civilian forensic investigations," said the study's lead author, Les R. Folio, D.O., M.P.H., from the Uniformed Services University in Bethesda, Md. U.S. troops stationed in Iraq and Afghanistan face threats from increased sniper activity and ...

Shellfish safer to eat thanks to breakthrough by Queen's scientists

2011-01-11
New technology to make shellfish safer to eat has been pioneered by scientists at Queen's University Belfast. The new test, developed at Queen's Institute for Agri-Food and Land Use, not only ensures shellfish are free of toxins before they reach the food chain but is likely to revolutionise the global fishing industry. While the current process for monitoring potentially dangerous toxins in shellfish takes up to two days, the new test slashes the testing time to just 30 minutes using new biosensor technology and provides a much more reliable result. The test detects ...

A Resolution You Can Keep -- Bay Area Hypnotherapy of San Francisco Challenges You to Succeed in 2011

2011-01-11
Jim and Lynn Swearingen, Co-Founders of Bay Area Hypnotherapy in San Francisco, want to give you a resolution you can keep! "During the months of January and February", said Lynn, "we are offering a $65 coupon for your first Hypnotherapy session, good toward any goal you wish to achieve. This is a whopping $30 off our usual price for an individual session. We're passing this savings on to you because we want everyone to discover what a powerful part their subconscious plays in directing their lives. We can teach you how to use self-hypnosis to achieve lasting change and, ...

Century 21 All Islands Hawaii Real Estate Agent, Oleg Potemkin, Attends Special Training, Builds Expertise in Luxury Real Estate Market.

2011-01-11
Hawaii real estate agent, Oleg Potemkin with CENTURY 21 All Islands, recently completed a luxury home marketing training course offered by the Institute for Luxury Home Marketing. The course - which covered such topics as demographics of the affluent, lifestyle segmentation, trends and amenities in today's luxury home product, and creating a marketing plan for the multimillion dollar property - was taught by Laurie Moore-Moore, President of the Dallas-based Institute for Luxury Home Marketing and author of the book, Rich Buyer, Rich Seller! The Real Estate Agents' Guide ...

Benefits of Public Bank Gold Investment - Eldora - Gold Bullion Resources

2011-01-11
It is important to research and evaluate each of the gold investment companies under consideration. There are many gold investment scams, fraud, boiler rooms that you should watch for, this will serve as a good warning before investing and only use gold options and companies that are verified, and have a good business reputation. This will minimize the risk of falling prey to any boiler rooms, scams or frauds. Gold stock investments are often included in the portfolio of investment companies which specialize in gold and other precious metals. Because the gold investment ...

Canadian Author Launches Murder Mystery Series

2011-01-11
A totally new mystery series is born! In the likeness of Agatha Christie's Miss Marple and Hercule Poroit; Conan Doyle's Sherlock Holmes; Patricia Cornwall's Dr. Kay Scarpetta; Erle Stanley Gardner's Perry Mason; Mickey Spillane's Mike Hammer and Rex Stout's Nero Wolfe, emerges a Toronto based, contemporary and powerful international business baron turned sleuth by using his resources and connections: Introducing Faison Quay in "Triple Mayhem", a murder mystery trilogy of the series first three novels: 'Now That I'm Gone', 'In The Absence Of Passion' and 'Narcissus' Reflection'. ...

Get Great Deals on Used Engines for Sale and the Right Places to Find Them

2011-01-11
Many car owners usually dread having to buy an engine as they are usually too expensive which causes financial strain on the individuals. The sad fact is that without it, one cannot be able to operate the car rendering it useless. However, one does not have to worry as (http://www.icarenginesforsale.com/discount-used-engines-sale.htm) Used Engines for Sale comes in to save the day by offering individuals the opportunity to benefit from discounted used engines that have been put up for sale. This helps an individual to save money and get their vehicles up and running without ...

Hottest Fat Burning Foods to Turbocharge Your Metabolism? New Diet Solution Uncovers All!

2011-01-11
Isabel De Los Rios is a food nutrition and exercise specialist with over a decade of expertise helping people accomplish their ideal weight and tackle problems which includes diabetes, cardiovascular disease, and high-cholesterol. Rios acquired a pre-med degree in exercise physiology from Rutgers University and is a professional Holistic Nutrition Lifestyle Coach. Her all natural, scientifically based Diet Solution Program has helped more than 50,000 people lose weight permanently simply by focusing on healthy, metabolism-boosting foods. Dieters eager to kick start ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] GEN reports on biotech acquisition deals in 2010 that topped $1 billion